Prof. Dr. Maged S. Abdel-Kader graduated from the College of Pharmacy, Alexandria University, in 1984 with a distinguished Degree of Honor. He earned his master's degree from Alexandria University in Pharmacognosy in 1989, followed by a Ph.D. through the Sharing program, studying with Prof. Frank Stermitz at Colorado State University. He was the winner of the 34th ASP Travel Grant for Graduate Students in 1993. Dr Maged S. Abdel-Kader was a member of Prof. Kingston group between 1996 and 1999 as a post-doctorate fellow. He was the winner of the Scientific Encouragements Award from the University of Alexandria in 2002. In 2003, he transferred to the College of Pharmacy, KSU, and in 2009, he joined Prince Sattam Bin Abdulaziz University. He served as the Prof. of Sheikh Abdullah bin Zaid bin Ghonaim Research Chair of Prophetic Medicine, developing and manufacturing natural products. Prof. Dr. Maged S. Abdel-Kader was selected as the best researcher at Prince Sattam Bin Abdulaziz University for the years 2016-2017. Prof. Maged Saad Abdel-Kader has published more than 230 works in the field of natural products, including five book chapters and three patents registered at the Saudi Authority of Intellectual Property. He has more than 3200 citations, 29 h-indexes, and 101 i10-indexes.
Mohamed M. Radwan is a Senior Research Scientist at the National Center for Natural Products Research, School of Pharmacy, University of Mississippi, USA. He also serves as a Professor at the Faculty of Pharmacy, University of Alexandria, Egypt. He obtained his B.S. in Pharmacy, M.S. in Pharmacy and Pharmaceutical Sciences (Pharmacognosy), and Ph.D. in Pharmacy (Pharmacognosy) from the University of Alexandria in 1994, 2001, and 2005, respectively. Dr. Radwan’s research interests include isolation and structure elucidation of biologically active metabolites from plant, fungal and marine sources, as well as marijuana research. He has worked on many projects funded by the NIH focusing on the isolation and characterization of the components of high-potency marijuana and the evaluation of their pharmacology, and their interaction with CB1 and CB2 receptors. He has also isolated and characterized active secondary metabolites from endophytic fungi, plants, mushrooms, and marines with significant activity against Methicillin-Resistant Staphylococcus aureus (MRSA) microorganisms, malaria and leishmania. He engaged in many projects aiming at the development and validation of the analysis of cannabinoids, terpenes, and flavonoids using UPLC, HPLC, GC/FID, and GC/MS techniques. Currently, he is working in the large-scale production of THC and Other cannabinoids (g to kg quantity) by using chemical and chromatographic techniques.
Dr. Ahmed M. Metwaly is an Associate Professor at the Faculty of Pharmacy, University of Al-Azhar, Cairo, Egypt. He has been recognized among the top 2% of the most impactful scientists in the world, according to Stanford's rankings for both 2022 and 2023. He was a Senior Research Fellow at Liaoning University of Traditional Chinese Medicine, Dalian, 116600, China (2018–2019), and a Visiting Scholar at the National Center for Natural Products Research, School of Pharmacy, University of Mississippi, Oxford, 38677, USA (2012–2014). Dr. Metwaly boasts a prolific publication record, having authored over 100 peer-reviewed scholarly articles featured in esteemed international journals. His research focuses on the isolation, characterization, computational, and mechanistic studies of active secondary metabolites and synthesized compounds.
Prof. Dr. Ibrahim H. Eissa is an Associate Professor of Medicinal Chemistry and the Manager of the Quality Assurance Unit at the Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt. He obtained his B.Sc. in 2003, his M.Sc. in Medicinal Chemistry in 2009, and his Ph.D. degree in 2012, all from the Faculty of Pharmacy (Boys), Al-Azhar University. Since 2017, he has been an Associate Professor at Al-Azhar University, and was made a manager of QAU in 2018. His scientific activity is focused on the design, molecular modeling studies and synthesis of new bioactive compounds with potential anticancer activity against EGFR, VEGFR-2, Topoisomerases, tubulins, carbonic anhydrases, and thymidylate synthase. Recently, he has been interested in the design and discovery of SARS-CoV-2 inhibitors.
Prof. Dr. Mahmoud A. ElSohly is a Professor of Pharmaceutics and Drug Delivery at the National Center for Natural Products Research, School of Pharmacy, University of Mississippi. He obtained his B.A. in Pharmacy from Cairo University in 1966, his M.S. in Pharmacognosy from Cairo University in 1971, and his Ph.D. in Pharmacognosy from the University of Pittsburgh Main Campus in 1975. His areas of interest are in cannabis and cannabinoids chemistry, product development activities, isolation and characterization of natural products, and development of analytical procedures for a wide range of compounds with emphasis on pharmacologically active ones.
